SYK vs BSX
SYK and BSX side by side — valuation & fundamentals (public data).
Key statistics
| Metric | SYKSTRYKER CORP | BSXBOSTON SCIENTIFIC CORP |
|---|---|---|
| Market cap | $124.88B | $69.46B |
| P/E (TTM) | 33.7 | 19.6 |
| P/B | 10.65 | 2.69 |
| P/S | 5.0x | 3.3x |
| Dividend yield | 1.03% | — |
| Revenue | $25.84B(TTM) | $20.61B(TTM) |
| Revenue growth (YoY) | 11.2% | 19.9% |
| Net income | $3.73B(TTM) | — |
| Earnings growth (YoY) | 8.5% | — |
| EPS, diluted | $9.65(TTM) | $2.39(TTM) |
| EBIT margin | 19.5% | 18.0% |
| ROE | 27.7% | 0.0% |
| ROIC | 15.1% | 10.5% |
| Piotroski F | 8/9 | — |
| 1y total return | -16.5% | -56.9% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: SYK vs BSX
| Metric | SYK | BSX |
|---|---|---|
| End value | $34.0K | $24.8K |
| Total return | +240.1% | +148.3% |
| CAGR | +12.6% | +9.2% |
| Volatility | 26.4% | 27.3% |
| Sharpe | 0.44 | 0.32 |
| Sortino | 0.62 | 0.44 |
| Max drawdown | -43.8% | -60.6% |
Based on 2600 common trading days, 2016-03-30 → 2026-07-31 · risk-free 3.83% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)